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and from this automatically to quantify a bone structure marker strongly
associated with the presence of OA. The advantages of this approach are
the use of low cost MRI equipments and a fully automatic computer-
based framework, which makes the developed marker well suitable for
large longitudinal clinical studies.
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Purpose: Osteoarthritis (OA) involves cartilage degradation resulting
from biochemical changes. In this study we perform ex-vivo T1-rho
weighted MRI followed by high resolution magic angle spinning (HRMAS)
NMR spectroscopy at 11.7 T using knee articular cartilage acquired from
OA patients during total knee replacement (TKA) surgery. HRMAS ensures
tissue integrity and allows immuno-histochemistry (IHC) and histology
of the same cartilage samples following spectroscopy. We use immuno-
histochemistry and histology to show that the biochemical changes
measured with HRMAS correlate with the histopathology of cartilage,
and thus validate that HRMAS is a viable and powerful addition to our
capabilities to study early and late OA, and it complements the T1-
rho relaxation map acquired using ex-vivo MRI that depicts regions of
increased cartilage degradation in OA specimens.
Methods: Osteoarthritic samples were excised from OA patients (n = 4,
range = 57–81 years) undergoing TKA during surgery. In case of each
patient lateral and medial femoral condyles were acquired, ﬂash-frozen
in dry ice, then immediately stored at −80C until experiments. The
condyles were mounted and secured on a grid (Fig. 1) after thawing
to obtain T1-rho MRI of the ex-vivo specimens using a 3 Tesla GE
scanner. Semi-automatic segmentation software developed in-house
was used to segment the cartilage overlying the condyles and the
mean+SD of T1rho was determined in each case. 8 cartilage punches
were acquired per patient using a 3mm punch resulting in a total of
n = 24 punches. The samples were then analyzed using HRMAS NMR
spectroscopy using a Carr Purcell Meiboom Gill (CPMG) pulse sequence
to determine the biochemical composition of the samples. Following
HRMAS, histologic (hematoxylin/eosin and Safranin-O/Fast Green) and
immunohistochemical evaluation were performed on the same samples
using antibodies that recognize aggrecan cleavage neoepitopes G1-
NITEGE (reﬂecting activities of ADAMTS) and G1-VDIPEN (reﬂecting
activities of MMPs) as well as those that recognize the collagen-II
cleavage neoepitopes (GPQG).
Fig. 1. OA knee cartilage/bone specimen ﬁxed on a plastic grid for MRI
ex-vivo scan.
Results: Figure 2(A) shows a representative segmented ex-vivo T1-rho
weighted MRI color map of the lateral inferior femoral condyle of an OA
patient. The mean+ SD of T1-rho for the segmented cartilage was (60.4+
18.45) ms. The corresponding HRMAS spectra of the punch sample shown
in 2(A) is indicated in Figure 2(B), with well resolved spectral peaks
including N-acetyl (reﬂecting proteoglycan concentration) and alanine
(reﬂecting collagen concentration). Figure 3 shows the H&E staining,
Safranin-O staining and the immuno-histochemical labeling of anti-
NITEGE of the same punch sample as was used for HRMAS acquisition.
Conclusions: This study is a multi-modality approach to understand the
biochemical changes involved in OA. The use of HRMAS spectroscopy
after performing ex-vivo T1-rho MRI allows the correlation of T1-
rho relaxation with biochemical proﬁles of cartilage as determined
by HRMAS. The fact that cartilage samples remain intact after HRMAS
provides the ability to perform histo-pathological analysis of the same
cartilage samples. Quantitative analysis of T1-rho values, HRMAS spectral
quantiﬁcation and histology/IHC staining grading will be performed with
data collected from this study. This technique provides a validation of
spectroscopy approach and helps establish potential biomarkers of the
cartilage degradation process in OA.
Fig. 2. (A) Representative ex-vivo T1-rho weighted MRI of osteoarthritic
femoral condyle and (B) the corresponding HRMAS spectra of a cartilage
punch (indicated in A) acquired from the same femoral condyle
indicating the resonance arising from the N-acetyl side-chain protons of
proteoglycan and the alanine resonance corresponding to the collagen.
Fig. 3. Histological/immunohistochemical sections of cartilage (the same
punch sample as in Figure 2) stained using (A) H&E, (B) Safranin-O,
(C) anti-NITEGE.
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Purpose: Biomarkers of cartilage metabolism have potential to identify
early stages of osteoarthritis (OA), before clinical evidence is present,
and thus facilitate early diagnosis and therapy. The purpose of this study
was to identify synovial ﬂuid (SF) and serum biomarker changes that
occur after acute joint injury using an equine model of early OA. We
hypothesized that collagen biomarkers would identify early metabolic
changes that occur secondary to acute osteochondral (OC) injury.
Methods: Twenty-two clinically and radiographically normal age- and
sex-matched Quarter Horses were randomly divided into 2 groups:
(1) horses (n =11) that had an OC fragment created arthroscopically
on the dorsomedial aspect of the ﬁrst phalanx in one randomly
selected metacarpophalangeal (MCP) joint and a sham operation in the
contralateral joint at week 0; and (2) unoperated exercise control horses
(n = 11). All horses were exercised on a high-speed treadmill 5 days/week
from week 2 to week 16. Blood was collected from the jugular vein and SF
samples were collected without lavage from both MCP joints of all horses
at baseline (week 0), week 2, 8, and 16. Commercially available collagen
degradation (CTXII [IDS/Nordic], C2C, C12C [IBEX]) and synthesis (CPII
[IBEX]) ELISA assays were used to analyze SF and serum samples. All
assays were previously validated for equine use. Data was assessed for
normality and outliers were removed from further analyses. A repeated
measures ANOVA with a Tukey’s test for multiple comparisons was used
for all analyses. P≤ 0.05 was considered signiﬁcant. All procedures were
approved by institutional animal care and use committees.
